Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapy-related myeloid neoplasm in a patient with TP53 mutation: a dilemma in allogeneic stem cell transplant.

Leukemia & lymphoma - 1 Jun 2010

Kim Min Kyoung, Cho Hee Soon, Bae Young Kyung, Lee Kyung Hee, Ki Chang-Seok, Lee Seung-Tae, Hyun Myung Soo

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Diagnosis, Differential
Share to Leukemia, Myeloid
Share to Neoplasms, Second Primary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Risk Assessment

Share to Stem Cell Transplantation

Share to Transplantation, Homologous

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 20443677
DOI: 10.3109/10428191003802357

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapy-related myeloid neoplasm in a patient with TP53 mutation: a dilemma in allogeneic stem cell transplant.PMID 20443677Read ↗

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.Semantic proximity Read ↗

Therapy-related myeloid neoplasms.Semantic proximity Read ↗

Transplant options and outcomes for TP53 myeloid disease.Semantic proximity Read ↗

Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts.Semantic proximity Read ↗

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.Semantic proximity Read ↗

Therapy-related myeloid neoplasms: what's in a name?Semantic proximity Read ↗

Nontransplant treatment approaches for myeloid neoplasm with mutated TP53.Semantic proximity Read ↗

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.Semantic proximity Read ↗

Preexisting TP53 mutation in therapy-related acute myeloid leukemia.Semantic proximity Read ↗

TP53 mutations in therapy-related acute myeloid leukemia: still the dark side of the moon?Semantic proximity Read ↗

Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: report of two cases.Semantic proximity Read ↗

<i>TP53</i>mutation screening for patients at risk of myeloid malignancySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.